Implementing Pharmacogenetic Testing as a Risk Reduction Strategy for Drug Users
Ther Drug Monit
.
2024 Dec 1;46(6):841-842.
doi: 10.1097/FTD.0000000000001262.
Epub 2024 Sep 26.
Authors
Guillaume Drevin
1
,
Marie Briet
1
2
3
,
Chadi Abbara
1
Affiliations
1
Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, Angers, France.
2
Université d'Angers, Angers, France.
3
Université Angers, UMR CNRS 6015, Inserm U1083, Unité MitoVasc, Team Carme, SFR ICAT, Angers, France.
PMID:
39331839
DOI:
10.1097/FTD.0000000000001262
No abstract available